Abel Hall, LLC Harvard Bioscience Inc Transaction History
Abel Hall, LLC
- $216 Billion
- Q2 2025
A detailed history of Abel Hall, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Abel Hall, LLC holds 37,334 shares of HBIO stock, worth $15,306. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,334Holding current value
$15,306% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HBIO
# of Institutions
76Shares Held
22.6MCall Options Held
101KPut Options Held
22K-
Amh Equity LTD3.51MShares$1.44 Million2.13% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.17 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.14MShares$877,8500.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$760,0950.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.5MShares$615,6180.03% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $17.1M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...